The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sushma Kakani

Sushma Kakani, a promoter of Godavari Drugs Ltd, acquired 4,23,000 convertible warrants through a preferential allotment on 18 March 2026, as disclosed under SEBI Takeover Regulations. Before the acquisition, she held 11,55,000 equity shares (15.34% of voting capital); after adding the warrants, her total potential holding rises to 15,78,000 units (11.40% of equity, 12.64% on a fully diluted basis). The company's equity share capital expanded significantly from 75,30,500 shares to 1,01,27,435 shares as part of the preferential issue, with total diluted share capital now standing at 1,24,87,500 shares. The warrants give the promoter the right to convert into equity shares at a later date, increasing her eventual economic interest in the company.